Table 1 Congenital Rhabdomyosarcoma: review of the literature

Gender: female/male (sex ratio)

5/11 (0.45)

10/7 (1.4)

 PM head & neck

–

1

 Non PM head & neck

6

4

 Orbit

–

–

 GU non bladder-prostate

2

–

 GU bladder-prostate

2

–

 Extremities

1

7

 Other site

5^a

4^b

 NA

–

1

 I

1

–

 II

4

1

 III

11

3

 IV

1

13^c

 Negative

2

5

 NA

12

8

 PAX3-FOXO1 positive

–

3

 PAX7-FOXO1 positive

–

–

 Others

2 [t(2;8)]

1 [N-myc amplification]

 NA

–

1

 Surgery only

2

–

 Chemotherapy only

2

9

 Chemotherapy + surgery

9

4

 Chemotherapy + surgery + radiotherapy

3

2

 Chemotherapy + radiotherapy

–

1

 Alive [median months from dg (range)]

8 [31.5 (6–240)]

4 [9 (6–240)]

 Dead

2

13^d

 NA

6

–